LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray

World Journal of Gastroenterology

Volumn 20, Issue 20, 2014, Pages 6314-6321

  Liu, Wu Tao ^a   Lu, Xin ^a   Tang, Guang Hua ^a   Ren, Jin Jun ^a   Liao, Wen Jun ^a   Ge, Peng Lei ^a   Huang, Jie Fu ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Expression signature; Hepatocellular carcinoma; Long non coding RNA; MALAT1; Microarray

Indexed keywords

COMPLEMENTARY RNA; LONG UNTRANSLATED RNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENE EXPRESSION ASSAY; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VALIDATION STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MIDDLE AGED; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING;

EID: 84901488404     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i20.6314     Document Type: Article

References (47)

1. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524. [PMID: 11870363 DOI: 10.1053/jhep.2002.32089]
2. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255. [PMID: 22353262 DOI: 10.1016/ s0140-6736(11)61347-0]
3. Nguyen VT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat 2009; 16: 453-463. [PMID: 19302335 DOI: 10.1111/j.1365-2893.2009.01117.x]
4. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3: 353-367. [PMID: 19673623 DOI: 10.1586/egh.09.35]
5. Hao K, Luk JM, Lee NP, Mao M, Zhang C, Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, Poon RT. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 2009; 9: 389. [PMID: 19886989 DOI: 10.1186/1471-2407-9-389]
6. But DY, Lai CL, Yuen MF. Natural history of hepatitisrelated hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1652-1656. [PMID: 18350595 DOI: 10.3748/wjg.14.1652]
7. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236. [PMID: 21685461 DOI: 10.3322/caac.20121]
8. Willyard C. Researchers look for 'sweet' method to diagnose cancer. Nat Med 2007; 13: 1267. [PMID: 17987006 DOI: 10.1038/nm1107-1267]
9. Imbeaud S, Ladeiro Y, Zucman-Rossi J. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. Semin Liver Dis 2010; 30: 75-86. [PMID: 20175035 DOI: 10.1055/s-0030-1247134]
10. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23: 1494-1504. [PMID: 19571179 DOI: 10.1101/gad.1800909]
11. Zhou H, Xiao B, Zhou F, Deng H, Zhang X, Lou Y, Gong Z, Du C, Guo J. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers 2012; 17: 104-110. [PMID: 22263628 DOI: 10.3109/1354750x.2011.614961]
12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233. [PMID: 19167326 DOI: 10.1016/j.cell.2009.01.002]
13. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-655. [PMID: 19239886 DOI: 10.1016/j.cell.2009.01.035]
14. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610. [PMID: 20661255 DOI: 10.1038/nrg2843]
15. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012; 279: 3159-3165. [PMID: 22776265 DOI: 10.1111/j.1742-4658.2012.08694.x]
16. Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC, Reis EM. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer 2011; 10: 141. [PMID: 22078386 DOI: 10.1186/1476-459 8-10-141]
17. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311-1323. [PMID: 17604720 DOI: 10.1016/ j.cell.2007.05.022]
18. Qureshi IA, Mattick JS, Mehler MF. Long non-coding RNAs in nervous system function and disease. Brain Res 2010; 1338: 20-35. [PMID: 20380817 DOI: 10.1016/j.brainres.2010.03.110]
19. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641. [PMID: 19239885 DOI: 10.1016/j.cell.2009.02.006]
20. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076. [PMID: 20393566 DOI: 10.1038/nature08975]
21. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, Shang JL, Gao CF, Zhang FR, Wang F, Sun SH. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54: 1679-1689. [PMID: 21769904 DOI: 10.1002/hep.24563]
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. [PMID: 11846609 DOI: 10.1006/meth.2001.1262]
23. Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159-166. [PMID: 23791884 DOI: 10.1016/ j.canlet.2013.06.013]
24. Brockdorff N, Ashworth A, Kay GF, McCabe VM, Norris DP, Cooper PJ, Swift S, Rastan S. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 1992; 71: 515-526. [PMID: 1423610]
25. Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res 2011; 71: 5365-5369. [PMID: 21828241 DOI: 10.1158/0008-5472.CAN-10-4379]
26. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003; 22: 8031-8041. [PMID: 12970751 DOI: 10.1038/ sj.onc.1206928]
27. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F, Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366-5383. [PMID: 20423907 DOI: 10.1093/nar/gkq285]
28. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354-361. [PMID: 21550244 DOI: 10.1016/j.tcb.2011.04.001]
29. He S, Liu S, Zhu H. The sequence, structure and evolutionary features of HOTAIR in mammals. BMC Evol Biol 2011; 11: 102. [PMID: 21496275 DOI: 10.1186/1471-2148-11-102]
30. Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, Wei M, Xu C, Wu C, Zhang Z, Gao X, Liu Z, Hou J, Huang J, Sun Y. Long noncoding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 2013; 49: 2949-2959. [PMID: 23726266 DOI: 10.1016/j.ejca.2013.04.026]
31. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y, Fang G. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol 2013; 139: 437-445. [PMID: 23143645 DOI: 10.1007/ s00432-012-1324-x]
32. Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, Perera RJ. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 2011; 71: 3852-3862. [PMID: 21558391 DOI: 10.1158/0008-5472.CAN-10-4460]
33. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F, Sun SH. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013; 49: 1083-1096. [PMID: 23395002 DOI: 10.1016/ j.molcel.2013.01.010]
34. Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, Liu Y, Qiu F. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst 2013; 9: 407-411. [PMID: 23295831 DOI: 10.1039/c2mb25386k]
35. Yang Y, Li H, Hou S, Hu B, Liu J, Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One 2013; 8: e65309. [PMID: 23741487 DOI: 10.1371/ journal.pone.0065309]
36. Augoff K, McCue B, Plow EF, Sossey-Alaoui K. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 2012; 11: 5. [PMID: 22289355 DOI: 10.1186/1476-4598-11-5]
37. Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Björkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet 2011; 20: 2225-2237. [PMID: 21421997 DOI: 10.1093/hmg/ddr111]
38. Xie H, Ma H, Zhou D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int 2013; 2013: 136106. [PMID: 23762823 DOI: 10.1155/2013/136106]
39. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 2007; 8: 39. [PMID: 17270048 DOI: 10.1186/1471-2164-8-39]
40. Änkö ML, Müller-McNicoll M, Brandl H, Curk T, Gorup C, Henry I, Ule J, Neugebauer KM. The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes. Genome Biol 2012; 13: R17. [PMID: 22436691 DOI: 10.1186/gb-2012-13-3-r17]
41. Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet 2012; 3: 219. [PMID: 23109937 DOI: 10.3389/fgene.2012.00219]
42. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, Ranganathan S, Michalopoulos GK. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006; 44: 1012-1024. [PMID: 17006932 DOI: 10.1002/hep.21328]
43. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007; 26: 851-858. [PMID: 16878148 DOI: 10.1038/sj.onc.1209846]
44. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012; 29: 1810-1816. [PMID: 21678027 DOI: 10.1007/s12032-011-0004-z]
45. Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J, Zhang Y, Chen J, Shen H, Hu Z. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012; 7: e35145. [PMID: 22493738 DOI: 10.1371/journal.pone.0035145]
46. Yang F, Yi F, Han X, Du Q, Liang Z. MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Lett 2013; 587: 3175-3181. [PMID: 23973260 DOI: 10.1016/j.febslet.2013.07.048]
47. Reis EM, Verjovski-Almeida S. Perspectives of Long Non-Coding RNAs in Cancer Diagnostics. Front Genet 2012; 3: 32. [PMID: 22408643 DOI: 10.3389/fgene.2012.00032]